Skip to main content
ACG 2024 Annual Meeting Main banner
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Award Winner
ACG Newsworthy Abstract
ACG Newsworthy Abstract
Registration Required
Registration Required
No CME
No CME
On-Demand Video
On-Demand Video
Livestream
Livestream
Back

Oral Paper Presentation

Annual Scientific Meeting
Paper/Abstract Presentations

Plenary Session 3A - Esophagus / Stomach / Practice Management

Tuesday, October 29, 2024
2:15 PM – 3:45 PM ET
Location: Terrace Ballroom 1

Presentations:

  • 2:15 PM – 2:25 PM ET
    GLP-1 Agonists Use Is Associated With Lower Use of PPI and Do Not Worsen Outcomes in Patients With GERD: A National Database Analysis

    Presenting Author: Luis M. Nieto, MD (he/him/his) – Emory University School of Medicine

  • 2:25 PM – 2:35 PM ET
    Abnormal Secondary Peristalsis Demonstrated by FLIP Panometry is Frequently Seen in Patients With Normal Peristalsis on High-Resolution Manometry

    Presenting Author: Rhea Fogla, MD (she/her/hers) – New York-Presbyterian / Weill Cornell Medical Center

  • 2:35 PM – 2:45 PM ET
    Incidence of Young-Onset Barrett’s Esophagus is Increasing: A Population-Based Study From a Multi-Institutional National Database

    Presenting Author: Anila Vasireddy, MD (she/her/hers) – University of Pennsylvania Health System

  • 2:45 PM – 2:55 PM ET
    High Economic Burden Yet Low Clinical Value: Why Is So Much Sucralfate Prescribed?

    Presenting Author: Neha Wadhavkar, MD – Brown University

  • 2:55 PM – 3:05 PM ET
    Efficacy of 10-day VAL (Vonoprazan, Amoxicillin, and Levofloxacin) vs 14-day Standard Triple Therapy for Helicobacter pylori Eradication A Multicenter Randomized Controlled Trial

    Presenting Author: Kachonsak Yongwatana, MD – Phramongkutklao Hospital

  • 3:05 PM – 3:15 PM ET
    Evaluating the Use of an On-Demand Telehealth Platform as a Mechanism to Prevent Emergency Department (ED) Visits for Patients Presenting With Gastrointestinal (GI) Symptoms

    Presenting Author: Naresh T. Gunaratnam, MD (he/him/his) – MNGI Digestive Health

  • 3:15 PM – 3:25 PM ET
    Cendakimab Efficacy and Safety in Adult and Adolescent Patients With Eosinophilic Esophagitis 48-Week Results From the Randomized, Placebo-Controlled, Phase 3 Study (Late-Breaking Abstract)

    Late Breaking Abstract Presenter: Evan S. Dellon, MD, MPH, FACG – University of North Carolina at Chapel Hill

  • 3:25 PM – 3:35 PM ET
    Efficacy, Safety and Immunogenicity of Subcutaneous Infliximab (CT-P13 SC) Monotherapy versus Combination Therapy With Immunosuppressants Post hoc Analysis of LIBERTY-CD and LIBERTY-UC Studies (Late-Breaking Abstract)

    Late Breaking Abstract Presenter: Bruce E. Sands, MD, MS, FACG – Icahn School of Medicine at Mount Sinai

  • 3:35 PM – 3:45 PM ET
    Impact of Elafibranor on Markers of Disease Activity and Progression in Patients With Advanced Primary Biliary Cholangitis (Late-Breaking Abstract)

    Late Breaking Abstract Presenter: Marlyn J. Mayo, MD, FACG (she/her/hers) – UT Southwestern Medical Center